StockData
Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc. (LXRX) stock

LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.78+0.03 (+1.71%)

Close on Nov 17, 2026Market cap $792.02MP/E –Yield –

Lexicon Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Lexicon Pharmaceuticals's enterprise value was $696.48M on Nov 11, 2026, against $434.62M a year earlier. Over the last 5 years it ranged from $29.62M to $900.73M, with a median of $283.12M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$696.48M+109.7%
2025Dec 31, 2025$332.21M+490.8%
2024Dec 31, 2024$56.23M-71.5%
2023Dec 29, 2023$197.43M+6.8%
2022Dec 30, 2022$184.87M-58.0%
2021Dec 31, 2021$440.01M+55.5%
2020Dec 31, 2020$282.88M-29.3%
2019Dec 31, 2019$400.02M-47.4%
2018Dec 31, 2018$759.80M-19.1%
2017Dec 29, 2017$939.23M-20.6%
2016Dec 30, 2016$1.18B+1.5%
2015Dec 31, 2015$1.17B+170.7%
2014Dec 31, 2014$430.68M-45.6%
2013Dec 31, 2013$792.02M-2.5%
2012Dec 31, 2012$812.07M–

More Lexicon Pharmaceuticals figures

See a number that looks wrong?